About Us
Privacy Policy
Terms of Service
Use Disclaimer
AfyaChain logo
Cart
Wishlist
Account
View all categories
Brands
New Arrivals
Trending
Offers
Best Sellers
Vendors
Home
Products
Antituberculosis medicines
Ethambutol
Product image unavailable

Ethambutol

Vendor: Marketplace supplier

Formulations: - Parenteral > General injections > IV: 1000 mg per 10 mL; 2000 mg per 20 mL Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 100 mg (hydrochloride); 400 mg (hydrochloride) Indications: - Other specified tuberculosis - Tuberculosis Source: EML workbook import

Product metadata will be available once the catalog entry is complete.

Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
View Cart
Formulations: - Parenteral > General injections > IV: 1000 mg per 10 mL; 2000 mg per 20 mL Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 100 mg (hydrochloride); 400 mg (hydrochloride) Indications: - Other specified tuberculosis - Tuberculosis Source: EML workbook import

Similar Products

P-Aminosalicylate Sodium

Formulations: - Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import

MOQ: 1
Kes0.00

Protionamide

Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import

MOQ: 1
Kes0.00

Pretomanid

Formulations: - Oral > Solid > tablet: 200 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import

MOQ: 1
Kes0.00

Pyrazinamide

Formulations: - Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg Indications: - Tuberculosis Source: EML workbook import

MOQ: 1
Kes0.00

Moxifloxacin

Formulations: - Oral > Solid > tablet: 400 mg Oral > Solid > dispersible tablet: 100 mg Indications: - Tuberculosis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import

MOQ: 1
Kes0.00

Meropenem

Formulations: - Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection Indications: - Multi-drug resistant Mycobacterium tuberculosis - Neonatal meningitis - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import

MOQ: 1
Kes0.00
Sign Up to Our Newsletter→

Ready to amplify your rewards? Drop your email and we'll be in touch soon.

AfyaChain logo

AfyaChain connects verified healthcare suppliers with institutional buyers through a more reliable and transparent procurement experience.

About Us

About UsPrivacy PolicyTerms of ServiceUse DisclaimerContact Support

Useful Links

Log InRegisterShipping PolicyFAQsReturn Policy

Quick Links

AccountView CartMy WishlistBest SellersPromotions

Get In Touch

3rd Floor, Building A2, Nairobi

+254 712345678

admin@afyachain.com

Xfino

© 2026 AfyaChain. All rights reserved.

Privacy PolicyTerms of ServiceUse DisclaimerAbout Us